Liver Research and Development Limited
Registered name: LIVER RESEARCH AND DEVELOPMENT LIMITED
Liver Research and Development Limited made £473k revenue and a £1.7m loss in the year to 30 Jun 2024.
Liver Research and Development Limited’s revenue grew 33% to £473k in the year to 30 Jun 2024, with a loss of £1.7m and 21 employees. The company is classified under “research and experimental development on biotechnology” and is based in London; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- London, London
- Age
- 14 yrs · since 2012
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Jun 2022 | 30 Jun 2023 | 30 Jun 2024 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £362k | £355k | £473k |
| Cost of sales | £1.5m | £1.5m | £2.1m |
| Gross profit | −£1.2m | −£1.2m | −£1.6m |
| Operating profit | −£1.2m | −£1.2m | −£1.7m |
| Profit before tax | −£1.2m | −£1.2m | −£1.7m |
| Profit after tax | −£1.2m | −£1.2m | −£1.7m |
| Profit (best available) | −£1.2m | −£1.2m | −£1.7m |
| Employees (average) | 21 | 23 | 21 |
| Ratios | |||
| Profit margin | −326.9% | −339% | −357.9% |
| Gross margin | −320.1% | −325.7% | −344.2% |
| Revenue per employee | £17.2k | £15.4k | £22.5k |
| Profit per employee | −£56.3k | −£52.3k | −£80.7k |
| Growth (year on year) | |||
| Revenue growth | — | ▼1.9% | ▲33.4% |
| Headcount growth | — | ▲9.5% | ▼8.7% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £640k | £0 | £0 |
| Net assets | −£4.3m | −£5.5m | −£7.2m |
| Fixed assets | £0 | £0 | £0 |
| Current assets | £640k | £640k | £278k |
| Debtors | £0 | £0 | £0 |
| Deferred income | £0 | £0 | £0 |
| Source | FullAccounts · bulk data Mar 2024 | FullAccounts · bulk data Mar 2024 | FullAccounts · bulk data Mar 2025 |
How the business works
- Profit margin
- −357.9%
- Profit ÷ revenue.
- Gross margin
- −344.2%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £22.5k
- Revenue ÷ average employees.
- Profit per employee
- −£80.7k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 0%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 0%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 0%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now −£7.2m
- Cash at bank
- —
- Now £0
- Headcount
- ▼9%
- Now 21
- Deferred income
- —
- Now £0
- Fixed assets
- —
- Now £0
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Similar profitable businesses
- Collaborative Community Against Coronavirus CICLondon · Research and experimental development on biotechnology
- Revenue
- £786k
- Profit
- £29.9k
- Staff
- 0
- Z7 Biotech LtdNottingham · Research and experimental development on biotechnology
- Revenue
- £196k
- Profit
- £62.9k
- Staff
- 2
- Nuritas UK LimitedLondon · Research and experimental development on biotechnology
- Revenue
- £1.2m
- Profit
- £88.8k
- Staff
- 4
- Adorx Therapeutics LimitedEdinburgh · Research and experimental development on biotechnology
- Revenue
- £1.2m
- Profit
- £211k
- Staff
- 0
- Clinicology Ltd.Guildford · Research and experimental development on biotechnology
- Revenue
- £1.4m
- Profit
- £79.1k
- Staff
- 7
Sources
Latest figures from FullAccounts for the year to 30 Jun 2024 (profit −£1.7m), from the Companies House accounts bulk data published Mar 2025. Spotted an error? Request a correction.
Updated from Companies House on 15 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.